Using ctDNA to guide radiotherapy for head and neck cancer
Treatments studied
Part of Cancer clinical trials.
This study looks at whether measuring a DNA fragment in the blood (called ctDNA) can help predict how well radiotherapy works for head and neck cancer. It may help doctors better tailor treatment for patients with stage III or IV disease.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a new diagnosis of head and neck cancer (mouth, throat, voice box, or sinus) that has not spread to other organs.
- Your cancer is at stage III or IV (but not stage IVc, meaning it hasn't spread far).
- You are able to do daily activities with some help if needed (WHO performance status 0–2).
- You are recommended for curative radiotherapy, with or without chemotherapy or targeted therapy.
- You have not had any prior treatment for this cancer, and you have not had another cancer in the last 5 years.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses a blood test to look for tiny bits of tumor DNA after treatment for head and neck cancer. It aims to see if this test can detect any remaining cancer cells early, so you and your doctor can make informed decisions.
This study looks at “circulating tumor DNA” (tumor DNA found in blood) in people with newly diagnosed, locally advanced head and neck squamous cell cancer. Researchers want to see how the blood DNA levels relate to the cancer and how it may guide treatment after surgery.
This trial studies a blood test (ctDNA) in people with a type of skin cancer called cutaneous squamous cell carcinoma. It aims to see if the test can help track the cancer and guide treatment decisions.
This study looks at how well two tests, a blood test (ctDNA) and an MRI scan, can track head and neck cancer during and after standard treatment with radiation and chemotherapy. It aims to improve how treatment response is measured.
This study uses a blood test called ctDNA to look for leftover lung cancer after surgery. Based on that result, the trial will help decide which treatment approach is best for you and may catch cancer returning earlier.
This study looks at whether a blood test that finds tumor DNA can help doctors choose the best treatment for rectal cancer, possibly allowing some patients to avoid surgery. It tests different chemotherapy and radiation combinations to see if the cancer disappears completely.
Hear when a new SCC - Squamous Cell Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.